Anne DeGroot, M.D.

CEO/CSO
EpiVax, Inc.

Poster(s):

• (W1230-02-11) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics and Vaccines Using In Silico and In Vitro Methods
  Wednesday, May 15, 2024

  12:30 PM – 1:30 PM PT

• (W1130-02-09) Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods
  Wednesday, May 15, 2024

  11:30 AM – 12:30 PM PT

• (T1130-02-11) Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods
  Tuesday, May 14, 2024

  11:30 AM – 12:30 PM PT